niacinamide and sesquiterpenes

niacinamide has been researched along with sesquiterpenes in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (20.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chaplin, DJ; Horsman, MR; Khalil, AA; Overgaard, J	1
Kim, HJ; Kim, SH; Kim, TS	1
Palsamy, P; Subramanian, S	1
Alves, RO; Boin, MF; Crocco, EI; Lellis, RF; Veasey, JV	1
Dively, GP; Evans, JD; Guseman, AJ; Hawthorne, DJ; Kunkle, G; Miller, K; Pettis, JS; vanEngelsdorp, D	1

Trials

1 trial(s) available for niacinamide and sesquiterpenes

Article	Year
A novel cream formulation containing nicotinamide 4%, arbutin 3%, bisabolol 1%, and retinaldehyde 0.05% for treatment of epidermal melasma. Cutis, 2015, Volume: 96, Issue:5 Topics: Administration, Cutaneous; Adolescent; Adult; Arbutin; Dermatologic Agents; Female; Humans; Image Processing, Computer-Assisted; Melanosis; Middle Aged; Monocyclic Sesquiterpenes; Niacinamide; Patient Satisfaction; Prospective Studies; Retinaldehyde; Sesquiterpenes; Severity of Illness Index; Skin Cream; Software; Treatment Outcome; Young Adult	2015

Article

Year

A novel cream formulation containing nicotinamide 4%, arbutin 3%, bisabolol 1%, and retinaldehyde 0.05% for treatment of epidermal melasma.

Cutis, 2015, Volume: 96, Issue:5

Topics: Administration, Cutaneous; Adolescent; Adult; Arbutin; Dermatologic Agents; Female; Humans; Image Processing, Computer-Assisted; Melanosis; Middle Aged; Monocyclic Sesquiterpenes; Niacinamide; Patient Satisfaction; Prospective Studies; Retinaldehyde; Sesquiterpenes; Severity of Illness Index; Skin Cream; Software; Treatment Outcome; Young Adult

2015

Other Studies

4 other study(ies) available for niacinamide and sesquiterpenes

Article	Year
The ability of nicotinamide to inhibit the growth of a C3H mouse mammary carcinoma. Acta oncologica (Stockholm, Sweden), 1995, Volume: 34, Issue:3 Topics: Animals; Antineoplastic Agents; Cell Division; Cyclohexanes; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Mice, Inbred Strains; Neovascularization, Pathologic; Niacinamide; Probability; Sesquiterpenes	1995
Differential involvement of protein kinase C in human promyelocytic leukemia cell differentiation enhanced by artemisinin. European journal of pharmacology, 2003, Dec-15, Volume: 482, Issue:1-3 Topics: Artemisinins; Cell Differentiation; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Niacinamide; Protein Kinase C; Sesquiterpenes; Tretinoin	2003
Resveratrol, a natural phytoalexin, normalizes hyperglycemia in streptozotocin-nicotinamide induced experimental diabetic rats. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2008, Volume: 62, Issue:9 Topics: Animals; Diabetes Mellitus, Experimental; Glucose Tolerance Test; Hyperglycemia; Hypoglycemic Agents; Male; Niacinamide; Phytoalexins; Rats; Rats, Wistar; Resveratrol; Sesquiterpenes; Stilbenes; Streptozocin; Terpenes	2008
Multi-Drug Resistance Transporters and a Mechanism-Based Strategy for Assessing Risks of Pesticide Combinations to Honey Bees. PloS one, 2016, Volume: 11, Issue:2 Topics: Animals; ATP-Binding Cassette Transporters; Bees; Biological Transport; Biphenyl Compounds; Carbamates; Cyclohexanes; Drug Resistance, Multiple; Environmental Exposure; Fatty Acids, Unsaturated; Insecticides; Ivermectin; Membrane Transport Proteins; Neonicotinoids; Niacinamide; Pyrazoles; Pyridines; Quercetin; Rhodamines; Risk Assessment; Sesquiterpenes; Verapamil	2016